Lumos Diagnostics Holdings Limited (ASX:LDX)
Australia · Delayed Price · Currency is AUD 0.1000
-0.0100 (-9.09%)
Oct 7, 2026, 4:10 PM AEST
ASX:LDX Market Cap
ASX:LDX has a market cap or net worth of 94.48 million as of October 7, 2026. That makes ASX:LDX the world's #28,476 most valuable public company and #643 in Australia. Its market cap has decreased by -19.85% in one year.
Market Cap
94.48M
Enterprise Value
80.77M
Revenue
19.07M
Global Rank
Country Rank
#643 Australia
PE Ratio
n/a
ChartMarket Cap Chart
Since July 5, 2021, ASX:LDX's market cap has decreased from 196.70M to 94.48M, a decrease of -51.97%. That is a compound annual growth rate of -13.01%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 7, 2026 | 94.48M | -57.89% |
| Dec 31, 2025 | 224.36M | 756.38% |
| Dec 31, 2024 | 26.20M | -25.44% |
| Dec 29, 2023 | 35.13M | 248.53% |
| Dec 30, 2022 | 10.08M | -93.27% |
| Dec 31, 2021 | 149.80M | -23.85% |
| Jul 5, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| EBR Systems | 219.82M |
| Aroa Biosurgery | 169.49M |
| EMVision Medical Devices | 145.01M |
| Saluda Medical | 104.59M |
| SomnoMed | 63.73M |
| Epiminder | 56.33M |
| Cyclopharm | 55.32M |
| Compumedics | 51.94M |